EQ compared with INO: revenue, margins and what each company keeps, and the suppliers and customers both name

EQEquillium, Inc.

Mkt capRevenueRevenue

INOInovio Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

EQEquillium, Inc.

INOInovio Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EQ1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±25.7%▲+17.41%×0.68

INO1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±32.2%▲+16.90%×0.52

= impliedEQ realized, solidINO realized, hatchedOne scale, both sides: full bar = 33%× = |realized| ÷ impliedSource: market data

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

INOInovio Pharmaceuticals, Inc.

0.62▼−20.32%· post 2.05

ClosedOct 30 '26

Mkt cap$62.3MRevenue$65,343Q1 FY25Revenue—

Compare

ClosedOct 30 '26

EQEquillium, Inc.

INOInovio Pharmaceuticals, Inc.

1.38▼−2.90%post 1.38

Price

0.62▼−20.32%post 2.05

$86.9M

Mkt cap

$62.3M

Q4 FY24$4M

Revenue

$65,343Q1 FY25

FY24$41M

Revenue

—

EQ1.38▼−2.90%vsINO0.62▼−20.32%ClosedOct 30 '26